The cell cryopreservation market involves freezing cells at very low temperatures, typically liquid nitrogen temperatures, to preserve them for future use. The cryopreservation process facilitates long term storage of cells such as stem cells, oocytes and sperms for future therapeutic applications or assisted reproduction. Stem cells are master cells with the ability to differentiate into other cell types and find applications in treating several diseases including cancer, blood disorders, heart disease and others.

The global cell cryopreservation market is estimated to be valued at US$ 263.58 billion in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031. Rapid advancements in regenerative medicine and stem cell therapy supported by growing investments in research and development are fueling demand for cell banking and cryopreservation.

Key Takeaways

Key players operating in the Cell Cryopreservation Market  Size are BASF, DSM, Kemin Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler, Sensient Technologies, Vitablend. Cell therapy and regenerative medicine are key application areas for cryopreserved cells and growing popularity of these therapies is driving demand for cell cryopreservation solutions globally. With increasing research in stem cell therapy for cancer, neurological disorders, injuries and wounds, the need for reliable storage of these cells is rising significantly. North America, Europe, and Asia Pacific represent major markets for cell cryopreservation. Increasing investments by market players as well as research institutes in developing economies is fueling market expansion in countries such as China, India and Brazil.

Gets More Insights on, Cell Cryopreservation Market